SMFG
PFE icon

Sumitomo Mitsui Financial Group’s Pfizer PFE Stock Holding History

Sumitomo Mitsui Financial Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.18M Sell
173,691
-9,756
-5% -$255K 0.08% 66
2026
Q1 		$5.15M Sell
183,447
-6,756
-4% -$180K 0.1% 62
2025
Q4 		$4.74M Buy
190,203
+27,199
+17% +$686K 0.08% 62
2025
Q3 		$4.15M Buy
163,004
+38,804
+31% +$958K 0.07% 62
2025
Q2 		$3.01M Buy
124,200
+11,345
+10% +$265K 0.05% 69
2025
Q1 		$2.86M Buy
112,855
+8,151
+8% +$213K 0.05% 68
2024
Q4 		$2.78M Sell
104,704
-18,513
-15% -$502K 0.04% 72
2024
Q3 		$3.57M Buy
123,217
+1,166
+1% +$34K 0.08% 63
2024
Q2 		$3.41M Buy
122,051
+6,120
+5% +$168K 0.11% 62
2024
Q1 		$3.22M Buy
115,931
+16,600
+17% +$461K 0.1% 62
2023
Q4 		$2.86M Sell
99,331
-23,794
-19% -$719K 0.09% 67
2023
Q3 		$4.08M Buy
123,125
+1,092
+0.9% +$38.6K 0.13% 57
2023
Q2 		$4.48M Buy
122,033
+3,932
+3% +$153K 0.14% 58
2023
Q1 		$4.82M Sell
118,101
-8,849
-7% -$382K 0.15% 59
2022
Q4 		$6.51M Sell
126,950
-19,201
-13% -$921K 0.25% 55
2022
Q3 		$6.4M Sell
146,151
-17,902
-11% -$870K 0.27% 52
2022
Q2 		$8.6M Sell
164,053
-27,516
-14% -$1.4M 0.24% 49
2022
Q1 		$9.92M Sell
191,569
-11,364
-6% -$590K 0.29% 54
2021
Q4 		$12M Buy
202,933
+6,249
+3% +$310K 0.34% 40
2021
Q3 		$8.46M Buy
196,684
+36,287
+23% +$1.61M 0.19% 56
2021
Q2 		$6.28M Buy
160,397
+32,434
+25% +$1.26M 0.14% 60
2021
Q1 		$4.64M Buy
127,963
+35,462
+38% +$1.26M 0.11% 59
2020
Q4 		$3.4M Buy
92,501
+90,772
+5,250% +$3.33M 0.08% 65
2020
Q3 		$59K Buy
+1,729
New +$60.6K ﹤0.01% 135
2019
Q2 		– Sell
-818
Closed -$33K – 130
2019
Q1 		$33K Buy
+818
New +$32.8K ﹤0.01% 109
2018
Q4 		– Sell
-22,279
Closed -$928K – 122
2018
Q3 		$928K Buy
+22,279
New +$858K 0.08% 58

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sumitomo Mitsui Financial Group's PFE Position: Q2 2026 in Review

Sumitomo Mitsui Financial Group reduced its Pfizer (PFE) stake by 5.3% in Q2 2026, selling an estimated $255K and leaving 173,691 shares worth $4.18M. The position accounts for 0.08% of the portfolio, ranked #66.

Sumitomo Mitsui Financial Group first reported a position in PFE in Q3 2018 and has held it in 26 quarters since. The position peaked at $12M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Sumitomo Mitsui Financial Group held 173,691 shares of Pfizer worth $4.18M as of Q2 2026.
  • Sumitomo Mitsui Financial Group sold 9,756 Pfizer shares in Q2 2026, an estimated $255K.
  • Pfizer made up 0.08% of Sumitomo Mitsui Financial Group's portfolio in Q2 2026, its #66 holding.
  • Sumitomo Mitsui Financial Group first reported a position in Pfizer in Q3 2018 and has held it in 26 quarters since.
  • Sumitomo Mitsui Financial Group's Pfizer position peaked at $12M in Q4 2021.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sumitomo Mitsui Financial Group's 13F filing for Q2 2026, filed 13 Aug 2026.